Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001203311-14-000020)

Filing Details

Accession Number:: 0001203311-14-000020
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-02-24 19:25:54
Reporting Period:: 2014-02-20

Filing Date:: 2014-02-24
Accepted Time:: 2014-02-24 19:25:54
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1060736	Seattle Genetics Inc	SGEN	Biological Products, (No Disgnostic Substances) (2836)	911874389

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1588467	G Jonathan Drachman	21823 30Th Drive Se Bothell WA 98021	Cmo & Evp, R & D	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2014-02-20	1,241	$53.25	48,670	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Drachman on September 16, 2013.
Amount of securities beneficially owned following reported transactions includes 48,500 Restricted Stock Units subject to vesting.